Neurocrine Biosciences, Inc. ( NBIX) - Key Metrics

NBIX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $9.50 $1.43 $1.35 $1.27
2026Q1 $8.10 $1.97 $1.45 $1.36
2025Q4 $8.10 $1.54 $3.90 $3.93
2025Q3 $8 $2.11 $2.29 $2.16
2025Q2 $6.94 $1.09 $1.03 $0.90

NBIX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 29.47
2026Q1 0% 16.72
2025Q4 0% 23.02
2025Q3 0% 16.63
2025Q2 0% 28.83

NBIX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.76% 0%
2026Q1 1.03% 0%
2025Q4 2.77% 0%
2025Q3 1.54% 0%
2025Q2 0.72% 0%

NBIX

Price: $142.44

52 week price:
122.14
186.12

Earnings Per Share: 6.65 USD

P/E Ratio: 24.29

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 490000

Ebitda: 15.0 million

Market Capitalization: 14.5 billion

Links: